Immunosuppressive treatment in familial dilated cardiomyopathy with biopsy-proven intramyocardial inflammation?

In a recent issue of the Journal , Mahon et al. [(1)][1]added substantially to the pathogenesis of familial dilated cardiomyopathy (DCM), elucidating that intramyocardial inflammation, as assessed by immunohistochemical quantification of CD3+ T-lymphocytes and abundance of endothelial cell adhesion